The selective amplification of PCID2 in CRC patients, in conjunction with the compelling oncogenic function of PCID2 in multiple CRC models, collectively indicates a critical role of PCID1 in CRC progression and metastasis. The gene discussed is PCID2; the disease is colorectal carcinoma.